Intracardiac T-wave Alternans and Ischemia
1 other identifier
observational
11
1 country
1
Brief Summary
T-wave alternans is a test that looks at microvolt changes in the T-wave on a beat to beat basis. The presence or absence of such changes has been shown to predict or exclude future arrhythmic events. The mechanism of T-wave alternans is unclear, but may relate to calcium metabolism in the heart, and may be affected by conditions such as ischemia or heart failure. The purpose of this study is to determine whether T-wave alternans, as measured through the lead of an implantable defibrillator, is produced by acute ischemia induced by occlusion during percutaneous coronary interventions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2008
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 28, 2008
CompletedFirst Posted
Study publicly available on registry
April 30, 2008
CompletedStudy Start
First participant enrolled
August 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2012
CompletedResults Posted
Study results publicly available
March 28, 2013
CompletedApril 19, 2013
April 1, 2013
3.9 years
April 28, 2008
February 15, 2013
April 11, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
Number of Subjects With Positive T Wave Studies During a Coronary Intervention
Positive T wave alternans is determined by a proprietary program using ECG recordings during a stress test. The result is reported as positive, negative, or indeterminate.
During the coronary intervention, upto 2 hours
Study Arms (1)
Medtronic defibrillator
Patients undergoing a percutaneous coronary intervention (PCI) with an implanted Medtronic defibrillator with the capability of telemetry of the intracardiac signal.
Interventions
PCI previously electively scheduled.
Eligibility Criteria
Patients with coronary artery disease (CAD) undergoing PCI that also have an appropriate Medtronic implantable defibrillator.
You may qualify if:
- patient with CAD undergoing PCI with appropriate Medtronic implantable defibrillator.
You may not qualify if:
- non-elective procedure
- non-qualifying defibrillator type.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Columbia Universitylead
- Medtroniccollaborator
Study Sites (1)
Columbia University Medical Center
New York, New York, 10032, United States
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Jose' Dizon, MD
- Organization
- Columbia University
Study Officials
- PRINCIPAL INVESTIGATOR
Jose M Dizon, MD
Columbia University
Publication Agreements
- PI is Sponsor Employee
- Yes
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assoc Professor of Clinical, Department of Medicine Cardiology
Study Record Dates
First Submitted
April 28, 2008
First Posted
April 30, 2008
Study Start
August 1, 2008
Primary Completion
July 1, 2012
Study Completion
July 1, 2012
Last Updated
April 19, 2013
Results First Posted
March 28, 2013
Record last verified: 2013-04